Monday, 26 February 2024

Molbio Diagnostics launches transformative scale up programme for healthcare innovation

An intensive 12-week cohort programme for understanding high impact technology acceleration and faster Go-To-Market (GTM) traction

Molbio Diagnostics, Goa-based player in point-of-care (POC) diagnostics, has launched ‘EDGE’- an  innovative scaleup partnership programme dedicated to accelerating game-changing healthcare technologies.

As a part of EDGE, Molbio Diagnostics will select high-potential medtech startups and, small and medium enterprises (SMEs) with groundbreaking solutions in rapid POC for high sensitivity immunodiagnostics and early cancer detection. 

The main objective of this programme is to help startups overcome critical hurdles in product development, translation and scaling up with the assistance of Molbio’s expertise, guidance and support. Participants will be able to leverage Molbio's extensive network and expertise to bring their innovation to a worldwide audience.

Over 12 weeks, selected participants will receive intensive mentorship, resources and expertise from Molbio's team of seasoned professionals. This culminates in the opportunity to forge co-development, manufacturing, or global sales partnerships with Molbio. 

At the end of the programme, Molbio will engage with a few cohort participants for future partnerships which will involve bridge funding for product co-development, licensing, sales and distribution. The programme will be conducted in hybrid mode and each cohort participant will receive bespoke guidance. 

Published on : 08th February, 2024